Wellington Partners
VC
1998
$1 000 000 M
Munich, Bavaria, Germany
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Wellington Partners is one of the most successful pan-European venture capital firms. With funds totalling over € 800 million, we have invested throughout Europe in companies that have the potential to become real market leaders for more than 15 years.
We are committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically lead financing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, our own commitment can go as high as € 15 million.
Providing funding is only one part of our business. After funding, the entrepreneurs we back have access to the advice and guidance of our complete team and our entire global network. Our investment professionals operate out of four offices, located in London, Munich, Zurich and Palo Alto. The pan-European and transatlantic makeup of our organisation enables us to support our portfolio in expanding globally.
To date, Wellington Partners has invested in more than 100 companies throughout Europe. We have been a part of great successes as well as dismal failures. In our view, success has always been the result of a great idea executed by a great team with strong leadership and commitment; plus an enormous amount of hard work and an ounce of luck, the good fortune to be in the right place at right time.
Industry
Region of investment
Wellington Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
WP III Life Sciences
|
Venture Capital (VC)
|
Biotechnology
Digital
Healthcare Services
Medical Devices
MedTech
Life Sciences
HealthTech
|
Pre-seed
Seed
|
Europe
|
$5-10 m
|
$88 M
|
January 2008
|
|
WP IV Life Sciences
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
HealthTech
|
Pre-seed
Seed
|
Europe
|
$5-10 m
|
$76 M
|
January 2012
|
|
WP V Life Sciences
|
Venture Capital (VC)
|
Biotechnology
Medical Devices
Life Sciences
HealthTech
|
Pre-seed
Seed
|
Europe
|
$5-10 m
|
$239 M
|
August 2019
|
